Dienogest a tablet used in the treatment of ovarian cyst
Phase 2
- Conditions
- Health Condition 1: N801- Endometriosis of ovary
- Registration Number
- CTRI/2020/04/024793
- Lead Sponsor
- KMC Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Ultrasonographic diagnosis of ovarian endometrioma with mean diameter of 40mm or less
2.Atleast one symptoms like dysmenorrhea,chronic pelvic pain, dyspareuria should be present
Exclusion Criteria
1.Patients planned for surgical management
2. any harmonal therapy undertaken within three months before enrollment
3. patients with suspected malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the efficacy of Tab Dienogest 2mg in reducing the size of endometriosis and related symptomsTimepoint: 6 Months
- Secondary Outcome Measures
Name Time Method Improvement in quality of lifeTimepoint: 6 months